Особенности Ремоделирования Левого Желудочка У Пациентов С Тиреотоксикозом В Сочетании С Ишемической Болезнью Сердца И Хронической Сердечной Недостаточностью

Пащенко, Е. В.; России, Фгбоу Во «Ростовский государственный медицинский университет» Минздрава; Чесникова, А. И.; Кудинов, В. И.; Терентьев, В. П.; Lankina, M. S.

doi:10.14341/conf22-25.09.21-267

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Пациент продолжает лечение по поводу ДТЗ, доза тиреостатиков уменьшена до 20 мг/сут с последующим контролем функции щитовидной железы. Назначение тиреостатиков в рамках комплексной терапии и достижение эутиреоидного состояния способствует значимому улучшению со сторо-ны сердечно-сосудистой системы: уменьшается частота нарушений ритма и проводимости, улучшается систолическая и диастолическая функция левого желудочка, значительно компенсируются признаки ХСН у пациентов с ИБС и сопутствующим тиреотоксикозом [23]. Также пациенту рекомендована консультация кардиолога для коррекции кардиопротективной терапии.…”

Section: клинический случайunclassified

Features of the course of diffuse toxic goiter in elderly patients

Bulgakova,

Kosareva,

Dolgikh

et al. 2023

Medicinskij sovet

View full text Add to dashboard Cite

Diffuse toxic goiter is one of the frequent endocrine pathologies that lead to damage to the cardiovascular system. The prevalence of thyrotoxicosis in people over 65 years of age is 15%. The clinic of thyrotoxicosis among elderly patients is nonspecific and asymptomatic. Asthenic symptoms prevail – increasing muscle weakness, weight loss, neurological symptoms, expressed in lethargy and depression, changes in the gastrointestinal tract, cardiovascular system. Elderly patients often have tachycardia, atrial fibrillation, atrial fibrillation, increasing heart failure, which is associated with age-related changes in the myocardium, concomitant atherosclerosis-associated diseases. Atrial fibrillation in patients with thyrotoxicosis increases the risk of thromboembolic complications. Low-symptomatic manifestations of thyrotoxicosis require a more thorough examination, including laboratory, hormonal and instrumental methods. This article considers a clinical case of an elderly patient with diffuse toxic goiter. The features of the clinical picture with the predominance of disorders from the cardiovascular system -interruptions in the work of the heart, increased shortness of breath, signs of increasing cardiovascular insufficiency are presented. Diagnostic studies, differential diagnostic search, confirming the presence of thyrotoxicosis and cardiovascular insufficiency were conducted. Appropriate treatment has been prescribed. An integrated approach in the treatment of patients with diffuse toxic goiter in combination with ischemic heart disease significantly improves the condition of patients, normalizes the thyrotoxic status, and, consequently, the state of the cardiovascular system against the background of the use of thyrostatics. Also, the wellbeing of patients improves because of correction of cardioprotective therapy, the heart rate is normalized, the signs of chronic heart failure are significantly compensated.

show abstract

Section: клинический случайunclassified

Features of the course of diffuse toxic goiter in elderly patients

Bulgakova,

Kosareva,

Dolgikh

et al. 2023

Medicinskij sovet

View full text Add to dashboard Cite

show abstract

“…Также и перенесенный инфаркт миокарда в анамнезе чаще встречался у пациентов с ХСНунФВ или ХСНнФВ по сравнению с пациентами с ХСНсФВ [23,24].…”

unclassified

Chronic heart failure with moderately low ejection fraction

Osipova,

Gosteva,

Shepel

et al. 2023

Humans and their Health

View full text Add to dashboard Cite

Chronic heart failure (CHF) as one of the cardiovascular complications is among the most frequent causes of death and repeated hospitalizations of patients, representing a great burden on the health care system. Currently, the assessment of left ventricular (LV) ejection fraction (EF) is the cornerstone of classification of patients with CHF, the main criterion for diagnosis, phenotyping, prognosis and decision on the choice of pharmacotherapy strategy. Traditionally, patients with heart failure were divided according to a threshold value of PV greater than or <50%. In 2016, CHF was divided into three subgroups depending on LVEF: CHF with low LVEF (HFrEF; LVEF <40%), CHF with moderately low LVEF (HFmrEF 40-49%), and preserved LVEF (HFрEF≥50%). At the same time, to date, the data on HFmrEF are extremely limited and are represented by single publications in this area. Therefore, the research aimed at studying this category of patients is very promising. The aim of the review is to analyze the current data on CHF, in particular epidemiology, etiology, clinical characteristics and prognosis of patients.

show abstract

Особенности Ремоделирования Левого Желудочка У Пациентов С Тиреотоксикозом В Сочетании С Ишемической Болезнью Сердца И Хронической Сердечной Недостаточностью

Cited by 2 publications

References 0 publications

Features of the course of diffuse toxic goiter in elderly patients

Features of the course of diffuse toxic goiter in elderly patients

Chronic heart failure with moderately low ejection fraction

Contact Info

Product

Resources

About